Epirubicin Hydrochloride

盐酸表柔比星

Report date: 2026/01/27 17:55:00
NME

Base Information

Drug NameEpirubicin Hydrochloride
Drug Alias NameEpirubicina Hydrochloride盐酸表阿霉素Epirubicine Hydrochloride盐酸表柔吡星表柔比星盐酸盐 +[21] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsSolid tumoursThrombosisExtranodal Extension +[25] 
Global Approved IndicationsUrinary Bladder NeoplasmsSoft Tissue NeoplasmsOvarian Neoplasms +[15] 
Approved Indications in ChinaUrinary Bladder NeoplasmsSoft Tissue NeoplasmsOvarian Neoplasms +[15] 
Original Approved Country/TerritoryFrance
Original Approved Date1982/06/28
Country/TerritoryBelgiumUnited StatesGermany +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncUniversity Medicine GreifswaldRuhr University Bochum +[6] 
Inactive CompaniesJules Bordet InstituteMansoura UniversityNanocarrier Co Ltd +[7] 
Active IndicationsUrinary Bladder NeoplasmsSoft Tissue NeoplasmsOvarian Neoplasms +[19] 
Inactive IndicationsSolid tumoursThrombosisExtranodal Extension +[6] 

Other Information

ATC CodeL01DB03
Related LinksWikipediaDrugBankKEGG